The first mutations leading to acute myeloid leukemia can arise in the human body as early as adolescence — decades before diagnosis. SciTechDaily reports this, according to infohub.kz.
Researchers from the University of Cambridge and University College London studied decades-old archived blood samples from 47 women who later developed this aggressive blood cancer, as well as from 46 healthy participants. In two-thirds of those who became ill, the first dangerous mutation arose before age 20, although the average age at diagnosis was 72.
Using DNA analysis and mathematical models, the scientists reconstructed the rate at which the altered cells divided. At an early stage, their numbers doubled over years, but each new mutation accelerated growth two- to threefold. Once four changes had accumulated in the cells, their numbers could double within just weeks.
In one-third of the affected women, groups of mutated cells — so-called clones — began to dominate the blood several years before the disease. At the same time, standard genetic tests often miss this threat, mistaking acquired abnormalities for inherited traits. The authors of the study, published in the journal Nature, now plan to test whether therapy can slow the growth of such cells and prevent the development of leukemia.


